You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antihistamines

Showing 1 - 25 of 392
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Eosinophilic Esophagitis Trial in Jacksonville (Famotidine, Loratadine, Placebo)

Terminated
Has Results
  • Eosinophilic Esophagitis
  • Jacksonville, Florida
    Mayo Clinic
Nov 28, 2022

Chronic Inducible Urticaria Trial (Remibrutinib, Placebo)

Not yet recruiting
  • Chronic Inducible Urticaria
  • (no location specified)
Jul 28, 2023

Chronic Spontaneous Urticaria Trial (LOU064)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Mar 21, 2023

SARS-CoV-2 Infection

Recruiting
  • COVID-19
  • Terrassa, Barcelona, Spain
  • +1 more
Aug 15, 2022

Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Xolair
  • (no location specified)
Sep 19, 2023

Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Sep 20, 2023

Chronic Spontaneous Urticaria Trial in Japan (LOU064)

Recruiting
  • Chronic Spontaneous Urticaria
  • Nagoya, Aichi, Japan
  • +11 more
Jul 14, 2022

Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)

Not yet recruiting
  • Chronic Idiopathic Urticaria
  • Omalizumab Injection
  • Xolair Prefilled Syringe
  • (no location specified)
Mar 7, 2023

Nephrolithiasis Trial in New York (Fexofenadine Hcl 180Mg Tab, Placebo)

Recruiting
  • Nephrolithiasis
  • Fexofenadine Hcl 180Mg Tab
  • Placebo
  • New York, New York
    Columbia University Irving Medical Center/NYP
Jul 16, 2021

Chronic Spontaneous Urticaria Trial in Worldwide (Benralizumab, Placebo and Benralizumab)

Active, not recruiting
  • Chronic Spontaneous Urticaria
  • Benralizumab
  • Placebo and Benralizumab
  • Scottsdale, Arizona
  • +39 more
Jan 16, 2023

Chronic Spontaneous Urticaria Trial in Japan (TAS5315 Dose 1, TAS5315 Dose 2, TAS5315 Dose 3)

Recruiting
  • Chronic Spontaneous Urticaria
  • TAS5315 Dose 1
  • +5 more
  • Fukuoka, Japan
  • +4 more
Aug 15, 2022

Chronic Spontaneous Urticaria Trial (LOU064 (blinded), )

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • LOU064 (blinded)
  • placebo
  • (no location specified)
Dec 23, 2022

Inflammatory Skin Disease Trial in Hangzhou (Chlorpheniramine-Codeine)

Unknown status
  • Inflammatory Skin Disease
  • Hangzhou, Zhejiang, China
    2 nd Affiliated Hospital, School of Medicine, Zhejiang Universit
Jun 16, 2021

Chronic Inducible Urticaria Trial in Worldwide (Ligelizumab, Placebo)

Terminated
  • Chronic Inducible Urticaria
  • Litchfield Park, Arizona
  • +64 more
Jan 26, 2023

Chronic Spontaneous Urticaria Trial in Germany, Poland, United States (LY3454738, Placebo)

Terminated
Has Results
  • Chronic Spontaneous Urticaria
  • Bakersfield, California
  • +24 more
Feb 14, 2022

Pruritus Trial in Leuven (Desloratadine Single Dose, Levocetirizine Single Dose, Desloratadine Fourfold Dose)

Completed
  • Pruritus
  • Desloratadine Single Dose
  • +3 more
  • Leuven, Belgium
    Center for Clinical Pharmacology
May 25, 2020

Allergic Rhinitis Trial in Melbourne (Grass pollen sublingual immunotherapy tablet, Control)

Completed
  • Allergic Rhinitis
  • Grass pollen sublingual immunotherapy tablet
  • Control
  • Melbourne, Victoria, Australia
    Department of Allergy, Immunology and Respiratory Medicine, The
Oct 12, 2020

Urticaria, Allergy Trial in Pathum Wan (IV Dexamethasone, Oral prednisolone)

Completed
  • Urticaria
  • Allergy
  • IV Dexamethasone
  • Oral prednisolone
  • Pathum Wan, Bangkok, Thailand
    Chulalongkorn Hospital
Feb 8, 2020

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Ligelizumab
  • +2 more
  • Gilbert, Arizona
  • +160 more
Dec 12, 2022

Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

Completed
  • Chronic Spontaneous Urticaria
  • Ligelizumab
  • +2 more
  • Birmingham, Alabama
  • +182 more
Aug 5, 2022

Atopic Dermatitis Trial in Spain (Probiotic mixture with three bacterial strains with maltodextrin as a carrier., Placebo

Recruiting
  • Atopic Dermatitis
  • Probiotic mixture with three bacterial strains with maltodextrin as a carrier.
  • Placebo comparator with maltodextrin as a carrier.
  • Elche, Alicante, Spain
  • +6 more
Jul 4, 2022

Chronic Idiopathic Urticaria Trial in Cincinnati (benralizumab, )

Completed
  • Chronic Idiopathic Urticaria
  • benralizumab
  • placebo
  • Cincinnati, Ohio
    Bernstein Clinical Research Center
Jul 8, 2019

Chronic Inducible Urticaria Trial in United States (barzolvolimab, Matching Placebo)

Recruiting
  • Chronic Inducible Urticaria
  • barzolvolimab
  • Matching Placebo
  • Birmingham, Alabama
  • +31 more
Jan 20, 2023

Post-Exercise Hypotension Trial in Newark (Moderate Intensity Aerobic Exercise)

Recruiting
  • Post-Exercise Hypotension
  • Moderate Intensity Aerobic Exercise
  • Newark, Delaware
    Department of Kinesiology and Applied Physiology, University of
Apr 18, 2023

Urticaria, Angiœdema Trial in Colombes (Placebo Oral Tablet, Cortancyl Oral Tablet, Levocetirizine Oral Tablet)

Recruiting
  • Urticaria
  • Angiœdema
  • Placebo Oral Tablet
  • +2 more
  • Colombes, Ile De France, France
    Hospital Louis MOURIER
Dec 7, 2022